5-fluorouracil exposure during the period of conception: report on two cases.
Two patients who were administered topical vaginal 5-fluorouracil for human papilloma virus lesions became pregnant during treatment. The outcomes in both cases were healthy with normal developmental landmarks at 6 months of age. This experience highlights the potential for a positive outcome.
Odom
L D
LD
Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta 30912.
Plouffe
L
L
Butler
W J
WJ
D000282:Administration, Intravaginal; D000328:Adult; D005260:Female; D005306:Fertilization; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D027383:Papillomaviridae; D011247:Pregnancy; D011256:Pregnancy Outcome; D014412:Tumor Virus Infections / Q000188:drug therapy*
D005472:Fluorouracil